BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19372786)

  • 1. The latent reservoir for HIV-1 in resting CD4+ T cells and other viral reservoirs during chronic infection: insights from treatment and treatment-interruption trials.
    Haggerty CM; Pitt E; Siliciano RF
    Curr Opin HIV AIDS; 2006 Jan; 1(1):62-8. PubMed ID: 19372786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
    Siliciano RF
    Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The latent reservoir for HIV-1 in resting CD4+ T cells: a barrier to cure.
    Siliciano JD; Siliciano RF
    Curr Opin HIV AIDS; 2006 Mar; 1(2):121-8. PubMed ID: 19372795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent HIV-1 reservoirs in children: considerations for therapy.
    Persaud D
    Curr Opin HIV AIDS; 2006 Mar; 1(2):174-8. PubMed ID: 19372804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term latent reservoir for HIV-1: discovery and clinical implications.
    Siliciano JD; Siliciano RF
    J Antimicrob Chemother; 2004 Jul; 54(1):6-9. PubMed ID: 15163657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of HIV persistence in HIV reservoirs.
    Mzingwane ML; Tiemessen CT
    Rev Med Virol; 2017 Mar; 27(2):. PubMed ID: 28128885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages and residual HIV infection.
    Crowe SM
    Curr Opin HIV AIDS; 2006 Mar; 1(2):129-33. PubMed ID: 19372796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection.
    Crowe S; Zhu T; Muller WA
    J Leukoc Biol; 2003 Nov; 74(5):635-41. PubMed ID: 12960232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
    Ananworanich J; Dubé K; Chomont N
    Curr Opin HIV AIDS; 2015 Jan; 10(1):18-28. PubMed ID: 25415421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking replication-competent HIV reservoirs in infected individuals.
    Chun TW
    Curr Opin HIV AIDS; 2013 Mar; 8(2):111-6. PubMed ID: 23380652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
    N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.
    Chun TW; Davey RT; Ostrowski M; Shawn Justement J; Engel D; Mullins JI; Fauci AS
    Nat Med; 2000 Jul; 6(7):757-61. PubMed ID: 10888923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meaning of DNA detection during the follow-up of HIV-1 infected patients: a brief review.
    Re MC; Vitone F; Bon I; Schiavone P; Gibellini D
    New Microbiol; 2006 Apr; 29(2):81-8. PubMed ID: 16841548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute HIV-1 infection: are we getting there?
    Cellerai C; Little SJ; Loes SK
    Curr Opin HIV AIDS; 2008 Jan; 3(1):67-74. PubMed ID: 19372946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
    Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
    AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.